Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7488 p140
9 February 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


New professional body should be built from Society

Society's Lambeth headquarters

Society’s Lambeth headquarters should be sold to finance new body

Pharmacy’s new professional body should be built on what is left of the Royal Pharmaceutical Society after its regulatory functions have been taken over by the planned General Pharmaceutical Council, the Pharmacists’ Defence Association has said.

But in order to achieve a clear dissociation from the past and underpin the new professional body’s finances, the PDA believes that both the new body and the regulator need to move out of the Society’s Lambeth headquarters, which should then be sold to finance the new organisation.

In its written submission to the Clarke Inquiry (PDF 460K), the PDA adds that the new leadership body should have a smaller council and a smaller staff. Moving out of London would mean that costs would be lower.

“Above all, it must learn how to become member-focused. This is a very substantial change on the current position,” the PDA says.

It adds: “The new professional body must become a vital component of a pharmacist’s professional existence by supporting competencies, providing practice materials, facilitating support networks, supporting its weakest members, providing professional leadership and promoting pharmacy to the wider world.”

It is also the PDA’s view that it should be the professional body, and not the regulator, that proposes and sets standards for the profession after appropriate consultation with its members and pharmacy employers. The regulator should then accept and police those standards.

As well as having a directly elected council, the PDA says that the professional body should have a “senior group” of separately elected pharmacists to acts as custodians and auditors of the new professional body and as trustees of its benevolent activities.

So far as membership goes, the PDA believes that the new body should provide a home for both generalist and specialist pharmacists — but without any requirement for them to be registered with the regulator — and for graduate pharmaceutical scientists. But it warns that accepting pharmacy technicians as full members, particularly if they are not university graduates, could undermine the whole structure.

“It is possible to see how, under such circumstances, pharmacists could actually lose what limited interest there was with the new professional body and, by leaving it, inadvertently create what could be a body primarily for pharmacy technicians,” it warns.

It further warns that any conflict between the interests of pharmacists and technicians as the Government seeks to give technicians more responsibility might cause the professional body to mute its defence of the role of pharmacists. This could render the new body useless in the eyes of pharmacists and lead to the creation of a rival organisation.

Back to Top


©The Pharmaceutical Journal